Cognex (CGNX) Holder Northstar Asset Management Raised Position by $807,640 as Stock Declined; Sarissa Capital Management LP Raised Its Achillion Pharmaceuticals (ACHN) Position by $726,400

May 23, 2018 - By Winifred Garcia

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Logo

Alex Denner increased its stake in Achillion Pharmaceuticals Inc (ACHN) by 17% based on its latest 2017Q4 regulatory filing with the SEC. Sarissa Capital Management Lp bought 363,200 shares as the company’s stock rose 28.04% while stock markets declined. The hedge fund run by Alex Denner held 2.50 million shares of the health care company at the end of 2017Q4, valued at $7.20M, up from 2.14M at the end of the previous reported quarter. Sarissa Capital Management Lp who had been investing in Achillion Pharmaceuticals Inc for a number of months, seems to be bullish on the $509.67M market cap company. The stock decreased 1.23% or $0.0458 during the last trading session, reaching $3.6842. About 346,305 shares traded. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) has declined 2.57% since May 23, 2017 and is downtrending. It has underperformed by 14.12% the S&P500.

Northstar Asset Management Llc increased its stake in Cognex Corporation (CGNX) by 109.88% based on its latest 2017Q4 regulatory filing with the SEC. Northstar Asset Management Llc bought 13,240 shares as the company’s stock declined 13.83% with the market. The institutional investor held 25,290 shares of the industrial machinery and components company at the end of 2017Q4, valued at $1.55 million, up from 12,050 at the end of the previous reported quarter. Northstar Asset Management Llc who had been investing in Cognex Corporation for a number of months, seems to be bullish on the $8.01 billion market cap company. The stock decreased 0.04% or $0.02 during the last trading session, reaching $46.32. About 585,553 shares traded. Cognex Corporation (NASDAQ:CGNX) has risen 31.99% since May 23, 2017 and is uptrending. It has outperformed by 20.44% the S&P500.

More news for Cognex Corporation (NASDAQ:CGNX) were recently published by: Seekingalpha.com, which released: “Will Cognex Stock Keep Falling?” on May 09, 2018. Streetinsider.com‘s article titled: “Pre-Open Movers 05/01: (INGN) (KPTI) (NTRI) Higher; (IVAC) (CGNX) (KLXI) Lower (more…)” and published on May 01, 2018 is yet another important article.

Since March 12, 2018, it had 0 insider buys, and 1 insider sale for $564,892 activity.

Among 19 analysts covering Cognex Corporation (NASDAQ:CGNX), 9 have Buy rating, 3 Sell and 7 Hold. Therefore 47% are positive. Cognex Corporation had 47 analyst reports since August 4, 2015 according to SRatingsIntel. CLSA upgraded the shares of CGNX in report on Monday, November 7 to “Outperform” rating. The company was maintained on Thursday, February 15 by Canaccord Genuity. Cowen & Co maintained Cognex Corporation (NASDAQ:CGNX) rating on Wednesday, August 2. Cowen & Co has “Buy” rating and $13500 target. Deutsche Bank initiated Cognex Corporation (NASDAQ:CGNX) rating on Thursday, December 8. Deutsche Bank has “Buy” rating and $74 target. The rating was maintained by Robert W. Baird with “Neutral” on Tuesday, October 31. The stock of Cognex Corporation (NASDAQ:CGNX) earned “Hold” rating by Canaccord Genuity on Tuesday, November 3. Needham maintained the shares of CGNX in report on Tuesday, November 1 with “Buy” rating. Canaccord Genuity upgraded the stock to “Buy” rating in Wednesday, November 18 report. The stock has “Buy” rating by Needham on Tuesday, August 4. Needham maintained it with “Buy” rating and $80 target in Friday, February 17 report.

Investors sentiment increased to 6.53 in 2017 Q4. Its up 5.48, from 1.05 in 2017Q3. It increased, as 32 investors sold CGNX shares while 21 reduced holdings. 84 funds opened positions while 262 raised stakes. 268.44 million shares or 268.52% more from 72.84 million shares in 2017Q3 were reported. Raymond James And owns 0.02% invested in Cognex Corporation (NASDAQ:CGNX) for 222,411 shares. Voya Ltd Liability Co owns 60,772 shares. State Street holds 0.03% or 5.47 million shares. Shine Invest Advisory Inc has 0.01% invested in Cognex Corporation (NASDAQ:CGNX). Creative Planning stated it has 17,852 shares or 0% of all its holdings. Gemmer Asset Limited Liability Com owns 284 shares. Boston Private Wealth Limited Company holds 0.04% in Cognex Corporation (NASDAQ:CGNX) or 19,324 shares. Magnetar Fincl Limited Liability Co, a Illinois-based fund reported 8,381 shares. Mackenzie Finance has invested 0.01% in Cognex Corporation (NASDAQ:CGNX). Riverbridge Prns Lc owns 377,022 shares for 0.45% of their portfolio. Nomura accumulated 4,130 shares. Bridgeway Capital Mgmt owns 84,200 shares or 0.06% of their US portfolio. 5,224 were reported by Silvercrest Asset Group Inc Ltd. Great Lakes Advsr Ltd Liability Corporation accumulated 0.01% or 4,291 shares. 925,139 were reported by Kayne Anderson Rudnick Management Ltd Liability Co.

Northstar Asset Management Llc, which manages about $241.97M US Long portfolio, decreased its stake in Foot Locker Inc (NYSE:FL) by 9,415 shares to 19,270 shares, valued at $903,000 in 2017Q4, according to the filing.

More notable recent Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) news were published by: Globenewswire.com which released: “Achillion Reports First Quarter 2018 Financial Results and Management Transition” on May 02, 2018, also Benzinga.com with their article: “23 Stocks Moving In Monday’s Pre-Market Session” published on May 21, 2018, Seekingalpha.com published: “Key events next week – healthcare” on May 18, 2018. More interesting news about Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) were released by: Benzinga.com and their article: “The Week Ahead In Biotech: PDUFA Dates, IPOs And More” published on May 21, 2018 as well as Benzinga.com‘s news article titled: “SMid-Cap Biotech: Barclays Downgrades Prothena, Upgrades Achillion” with publication date: May 21, 2018.

Investors sentiment increased to 2.08 in Q4 2017. Its up 1.12, from 0.96 in 2017Q3. It is positive, as 10 investors sold ACHN shares while 28 reduced holdings. 34 funds opened positions while 45 raised stakes. 110.36 million shares or 4.96% more from 105.14 million shares in 2017Q3 were reported. Bourgeon Ltd reported 48,504 shares. Great West Life Assurance Com Can accumulated 8,721 shares or 0% of the stock. Susquehanna Intll Grp Incorporated Llp reported 0% in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). Dafna Management Ltd Llc has 948,272 shares for 1.47% of their portfolio. Stifel Fincl Corporation has invested 0% of its portfolio in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). Meeder Asset Mgmt Inc owns 1,147 shares or 0% of their US portfolio. Arrowmark Colorado Holdg Lc owns 935,987 shares for 0.03% of their portfolio. Eventide Asset Mngmt Limited Company invested in 0.13% or 850,000 shares. Dimensional Fund Advsr Lp accumulated 4.73 million shares. Gp One Trading Ltd Partnership owns 18,061 shares. Moreover, California State Teachers Retirement Systems has 0% invested in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) for 184,465 shares. Retail Bank Of America De reported 0% stake. Ameritas has 10,118 shares. Goldman Sachs Gp, New York-based fund reported 3.00 million shares. 832,000 are owned by South Dakota Inv Council.

Cognex Corporation (NASDAQ:CGNX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>